Literature DB >> 18353489

The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.

Chris D Madsen1, Nicolai Sidenius.   

Abstract

The extracellular matrix (ECM) is a complex structural entity surrounding and supporting cells present in all tissue and organs. Cell-matrix interactions play fundamental roles during embryonic development, morphogenesis, tissue homoeostasis, wound healing, and tumourigenesis. Cell-matrix communication is kept in balance by physical contact and by transmembrane integrin receptors providing the dynamic link between the extracellular and intracellular environments through bi-directional signalling. The urokinase-type plasminogen activator receptor (uPAR) is a plasma membrane receptor overexpressed during inflammation and in almost all human cancers. One of its functions is to endorse ECM remodelling through the activation of plasminogen and downstream proteases, including matrix-metalloproteases (MMPs). Beside its role in ECM degradation, uPAR modulates cell-matrix contact through a direct engagement with the ECM component, vitronectin (Vn), and by regulating the activity state of integrins thus promoting or inhibiting integrin signalling and integrin-mediated cell adhesion to other ECM components, like fibronectin and collagen. In this review we have centred our attention on the non-proteolytic function of uPAR as a mediator of cell adhesion and downstream signalling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353489     DOI: 10.1016/j.ejcb.2008.02.003

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  37 in total

1.  Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.

Authors:  Andrew P Mazar; Richard W Ahn; Thomas V O'Halloran
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

2.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

3.  Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells.

Authors:  Gabriela Schneider; Malwina Suszynska; Sham Kakar; Mariusz Z Ratajczak
Journal:  J Cancer Stem Cell Res       Date:  2016-11-30

4.  Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.

Authors:  Michael E Yeager; Kelley L Colvin; Allen D Everett; Kurt R Stenmark; D Dunbar Ivy
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

5.  Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.

Authors:  Herbert B Schiller; Andreas Szekeres; Bernd R Binder; Hannes Stockinger; Vladimir Leksa
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

6.  Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.

Authors:  Francesca Margheri; Simona Serratì; Andrea Lapucci; Chillà Anastasia; Betti Giusti; Marco Pucci; Eugenio Torre; Francesca Bianchini; Lido Calorini; Adriana Albini; Agostina Ventura; Gabriella Fibbi; Mario Del Rosso
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

7.  Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.

Authors:  Lisa M Grove; Brian D Southern; Tong H Jin; Kimberly E White; Sailaja Paruchuri; Efrat Harel; Ying Wei; Shaik O Rahaman; Candece L Gladson; Qiang Ding; Charles S Craik; Harold A Chapman; Mitchell A Olman
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

8.  Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis.

Authors:  Ji-Hye Lee; Mee-Hye Oh; Jae-Seok Park; Gyoung-Jae Na; Hye-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

9.  Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.

Authors:  Nima Ghasemzedah; Salim S Hayek; Yi-An Ko; Danny J Eapen; Riyaz S Patel; Pankaj Manocha; Hatem Al Kassem; Mohamed Khayata; Emir Veledar; Dimitrios Kremastinos; Christian W Thorball; Tomasz Pielak; Sergey Sikora; A Maziar Zafari; Stamatios Lerakis; Laurence Sperling; Viola Vaccarino; Stephen E Epstein; Arshed A Quyyumi
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-03

10.  Fibulin-5, an integrin-binding matricellular protein: its function in development and disease.

Authors:  Hiromi Yanagisawa; Marie K Schluterman; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.